Chronic Hepatitis B Virus Infection Deteriorates Disease Outcome of Coronavirus Disease 2019 in Hamster.

Lunzhi Yuan,Xuan Liu,Yi Guan,Tong Cheng,Ningshao Xia

DOI: https://doi.org/10.1002/mco2.499

2024-01-01

MedComm

Abstract:Chronic hepatitis B virus infection deteriorates disease outcome of coronavirus disease 2019 in hamsterDear Editor, The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is widely recognized as a global public health crisis.Over the past three years, SARS-CoV-2 has been mutating and resulting in varying degrees of coronavirus disease 2019 (COVID-19), characterized by symptoms such as fever, cough, weakness, severe pneumonia, and even death.After the pandemic waves of the Delta and Omicron sublineages, the XBB variants of SARS-CoV-2 are still emerging in local areas.It has been reported that patients with chronic liver diseases, including those with chronic hepatitis B virus (HBV) infection, 1 are at a higher risk of experiencing poor outcomes from COVID-19.However, due to the lack of clinical samples and appropriate animal models, our understanding of various aspects of SARS-CoV-2 infection and the progression of COVID-19 in patients with chronic HBV infection (CHB) remains incomplete.Therefore, in this study, we aimed to replicate the dual infection of HBV and SARS-CoV-2 in a sensitive rodent model, namely the hamster.We infected 4-weekold male hamsters with AAV-HBV (1×10 9 vg per hamster) to establish persistent viremia of HBV surface antigen (HBsAg) (Figure S1).Subsequently, we mimicked different stages of chronic HBV infection in patients by intranasally infecting the hamsters with 1×10 4 PFU of the SARS-CoV-2 Delta variant at 4 weeks (4 W) and 16 weeks (16 W) after HBV infection.The control group consisted of hamsters infected solely with SARS-CoV-2.Interestingly, among the hamsters, six out of 12 control hamsters, one out of 12 HBV 4 W hamsters, and 10 out of 12 HBV 16 W hamsters died within 14 days post-infection (dpi) with SARS-CoV-2 (Figure 1A).Furthermore, at 7 dpi, the control, HBV 4 W, and HBV 16 W hamsters exhibited body weight losses of 15.13 ± 2.59%, 9.45 ± 2.47%, and 20.41 ± 3.18%, respectively (Figure 1B).These findings suggest that HBV 4 W and HBV 16 W hamsters developed contrary disease outcomes following SARS-CoV-2 infection.Y.L.